HIGHLIGHTS
- who: Cap et al. from the State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of have published the research: Generation and Immunogenicity of Recombinant, in the Journal: (JOURNAL)
- what: Previously, the studies showed that PRV variant based gE/gI- and gE/gI/TK-gene-deleted mutants were highly safe and efficacious in vulnerable animals and completely protected the immunized animals challenged by the lethal PRV Tianjin (PRV TJ) strain , demonstrating that the gene-deleted PRV could be used as a potential vector to manufacture virus-vectored vaccines. The aim of this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.